Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 202.50

-2.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: medsunman who wrote (27375)	1/12/1999 2:00:00 PM
From: Henry Niman	Read Replies (1) of 32384

medsunman, I agree with both of your posts. The Targretin news on diabetes has been discussed on this board many times, including the possibility that Targretin would not be used for diabetes, but would be used for advanced breast cancer. The diabetes program, because of the triglyceride levels (also discussed MANY times here before), would skip the first generation rexinoid (Targretin), and go directly to second generation (LGD1268 or LGD1324). I suspect that some of the moaners and groaners were so busy groaning and moaning about the "hype" on the board, that they actually missed the news, which was posted here 6-12 months ago. As far as new news is concerned, if LGND had new news, there would have been a press released BEFORE the presentation, just as there was for the news (presented at Bear Stearns) which gave rise to the first post on this thread).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next